Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1976 1
1996 1
2000 3
2001 2
2002 9
2003 7
2004 7
2005 9
2006 15
2007 7
2008 14
2009 13
2010 17
2011 17
2012 20
2013 13
2014 21
2015 21
2016 31
2017 27
2018 26
2019 31
2020 23
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

311 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: ut
Page 1
Chronic Obstructive Pulmonary Disease: Evaluation and Management.
Duffy SP, Criner GJ. Duffy SP, et al. Med Clin North Am. 2019 May;103(3):453-461. doi: 10.1016/j.mcna.2018.12.005. Epub 2019 Mar 14. Med Clin North Am. 2019. PMID: 30955513 Review.
Pulmonology referral is recommended for patients with COPD with symptoms despite first-line inhaled therapy, frequent exacerbations, any hospitalizations, or moderate-to-severe disease....
Pulmonology referral is recommended for patients with COPD with symptoms despite first-line inhaled therapy, frequent exacerbations, any …
Impact and prevention of severe exacerbations of COPD: a review of the evidence.
Halpin DM, Miravitlles M, Metzdorf N, Celli B. Halpin DM, et al. Int J Chron Obstruct Pulmon Dis. 2017 Oct 5;12:2891-2908. doi: 10.2147/COPD.S139470. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29062228 Free PMC article. Review.
Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical implications for patients and significant economic consequences for society. ...
Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical implications for patients and significant …
Epidemiology of Chronic Obstructive Pulmonary Disease: Prevalence, Morbidity, Mortality, and Risk Factors.
Rosenberg SR, Kalhan R, Mannino DM. Rosenberg SR, et al. Semin Respir Crit Care Med. 2015 Aug;36(4):457-69. doi: 10.1055/s-0035-1555607. Epub 2015 Aug 3. Semin Respir Crit Care Med. 2015. PMID: 26238634 Review.
Chronic obstructive pulmonary disease (COPD) remains a common and important cause of morbidity and mortality both in the United States and globally. The increasing trends of COPD prevalence, morbidity, and mortality seen in the later part of last century have not co …
Chronic obstructive pulmonary disease (COPD) remains a common and important cause of morbidity and mortality both in the United St
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
Wedzicha JA Ers Co-Chair, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, Criner GJ, Papi A, Rabe KF, Rigau D, Sliwinski P, Tonia T, Vestbo J, Wilson KC, Krishnan JA Ats Co-Chair. Wedzicha JA Ers Co-Chair, et al. Eur Respir J. 2017 Mar 15;49(3):1600791. doi: 10.1183/13993003.00791-2016. Print 2017 Mar. Eur Respir J. 2017. PMID: 28298398 Free article.
COPD Advanced Patient Management.
Criner GJ, Dreher M, D'Ambrosio CM, Zuwallack R, Geiseler J, Pépin JL. Criner GJ, et al. Chest. 2018 Jun;153(6):1497-1498. doi: 10.1016/j.chest.2018.03.054. Chest. 2018. PMID: 29884254 Review.
COPD is the third leading cause of death in the United States, with current rates of both morbidity and mortality persisting and contributing significantly to long-term disability. ...In particular, readmissions following COPD hospitalization are associated w …
COPD is the third leading cause of death in the United States, with current rates of both morbidity and mortality persisting a …
Metoprolol for the Prevention of Acute Exacerbations of COPD.
Dransfield MT, Voelker H, Bhatt SP, Brenner K, Casaburi R, Come CE, Cooper JAD, Criner GJ, Curtis JL, Han MK, Hatipoğlu U, Helgeson ES, Jain VV, Kalhan R, Kaminsky D, Kaner R, Kunisaki KM, Lambert AA, Lammi MR, Lindberg S, Make BJ, Martinez FJ, McEvoy C, Panos RJ, Reed RM, Scanlon PD, Sciurba FC, Smith A, Sriram PS, Stringer WW, Weingarten JA, Wells JM, Westfall E, Lazarus SC, Connett JE; BLOCK COPD Trial Group. Dransfield MT, et al. N Engl J Med. 2019 Dec 12;381(24):2304-2314. doi: 10.1056/NEJMoa1908142. Epub 2019 Oct 20. N Engl J Med. 2019. PMID: 31633896 Free PMC article. Clinical Trial.
Metoprolol was associated with a higher risk of exacerbation leading to hospitalization (hazard ratio, 1.91; 95% CI, 1.29 to 2.83). The frequency of side effects that were possibly related to metoprolol was similar in the two groups, as was the overall rate of nonrespirato …
Metoprolol was associated with a higher risk of exacerbation leading to hospitalization (hazard ratio, 1.91; 95% CI, 1.29 to 2.83). T …
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
Long-Term Oxygen Treatment Trial Research Group, Albert RK, Au DH, Blackford AL, Casaburi R, Cooper JA Jr, Criner GJ, Diaz P, Fuhlbrigge AL, Gay SE, Kanner RE, MacIntyre N, Martinez FJ, Panos RJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Stoller JK, Wise R, Yusen RD, Tonascia J, Sternberg AL, Bailey W. Long-Term Oxygen Treatment Trial Research Group, et al. N Engl J Med. 2016 Oct 27;375(17):1617-1627. doi: 10.1056/NEJMoa1604344. N Engl J Med. 2016. PMID: 27783918 Free PMC article. Clinical Trial.
In a time-to-event analysis, we found no significant difference between the supplemental-oxygen group and the no-supplemental-oxygen group in the time to death or first hospitalization (hazard ratio, 0.94; 95% confidence interval [CI], 0.79 to 1.12; P=0.52), nor in the rat …
In a time-to-event analysis, we found no significant difference between the supplemental-oxygen group and the no-supplemental-oxygen group i …
Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study.
Benzo R, Vickers K, Novotny PJ, Tucker S, Hoult J, Neuenfeldt P, Connett J, Lorig K, McEvoy C. Benzo R, et al. Am J Respir Crit Care Med. 2016 Sep 15;194(6):672-80. doi: 10.1164/rccm.201512-2503OC. Am J Respir Crit Care Med. 2016. PMID: 26953637 Free PMC article. Clinical Trial.
MEASUREMENTS AND MAIN RESULTS: We evaluated the rate of COPD-related hospitalizations during 1 year of follow-up. The absolute risk reductions of COPD-related rehospitalization in the health coaching group were 7.5% (P = 0.01), 11.0% (P = 0.02), 11.6% (P = 0.03), 11.4% (P …
MEASUREMENTS AND MAIN RESULTS: We evaluated the rate of COPD-related hospitalizations during 1 year of follow-up. The absolute risk r …
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.
Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK. Criner GJ, et al. Chest. 2015 Apr;147(4):894-942. doi: 10.1378/chest.14-1676. Chest. 2015. PMID: 25321320 Free PMC article. Review.
BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of symptoms of cough, dyspnea, and sputum production) is a major contributor to worsening lun …
BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as well as throughout the rest of the world. …
311 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page